Extracellular vesicles deliver sodium iodide symporter protein and promote cancer cell radioiodine therapy
Extracellular vesicles (EVs) are a promising carrier for various cargos with antitumor effects, but their capacity to transfer the ability to transport radioiodine for cancer theranostics remains unexplored. Herein, we tested the hypothesis that EVs can be loaded with the sodium iodide symporter (NI...
Main Authors: | Jung, K.-H (Author), Lee, J.H (Author), Lee, K.-H (Author), Mina, K. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Research
2022
|
Online Access: | View Fulltext in Publisher |
Similar Items
-
Relationship between Apoptosis Imaging and Radioiodine Therapy in Tumor Cells with Different Sodium Iodide Symporter Gene Expression
by: Kyung Oh Jung, et al.
Published: (2015-01-01) -
Glycosylation of Sodium/Iodide Symporter (NIS) Regulates Its Membrane Translocation and Radioiodine Uptake.
by: Taemoon Chung, et al.
Published: (2015-01-01) -
In Vivo Scintigraphic Imaging of Antitumor Effects by Combined Radioiodine Therapy and Human Sodium Iodide Symporter Gene Immunotherapy
by: Yun Choi, et al.
Published: (2010-05-01) -
Induction of sodium/iodide symporter (NIS) expression and radioiodine uptake in non-thyroid cancer cells.
by: Zhi Liu, et al.
Published: (2012-01-01) -
Enhancement of natural killer cell cytotoxicity by sodium/iodide symporter gene-mediated radioiodine pretreatment in breast cancer cells.
by: Hae Won Kim, et al.
Published: (2013-01-01)